JG
LEGN icon

Jefferies Group’s Legend Biotech LEGN Stock Holding History

Jefferies Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,000
Closed -$550K – 1803
2022
Q2 		$550K Buy
+10,000
New +$422K ﹤0.01% 958

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Jefferies Group's LEGN Position: Q2 2021 in Review

Jefferies Group sold out of Legend Biotech (LEGN) in Q2 2021, closing a stake of 21,000 shares — an estimated $609K sold.

Jefferies Group first reported a position in LEGN in Q1 2021 and held it in 1 quarter. The position peaked at $609K in Q1 2021. 86 funds tracked by Wall St. Rank hold LEGN as of Q2 2021.

  • Jefferies Group reported no remaining Legend Biotech position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 21,000 Legend Biotech shares in Q2 2021, an estimated $609K.
  • Jefferies Group first reported a position in Legend Biotech in Q1 2021 and held it in 1 quarter.
  • Jefferies Group's Legend Biotech position peaked at $609K in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.